Header cover image

Swedish (OMX) Healthcare Sector Analysis

UpdatedJan 12, 2025
DataAggregated Company Financials
Companies181
  • 7D-1.2%
  • 3M-2.5%
  • 1Y6.1%
  • YTD-2.0%

Over the last 7 days, the Healthcare industry has dropped 1.2%, driven by pullbacks in Sectra and Swedish Orphan Biovitrum of 3.8% and 1.8%, respectively. In the past year, the industry has gained 6.1%. Looking forward, earnings are forecast to grow by 41% annually.

Sector Valuation and Performance

Has the Swedish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 12 Jan 2025SEK 581.1bSEK 202.7b-SEK 2,498,780,680.0441.1x-232.5x2.9x
Tue, 10 Dec 2024SEK 573.6bSEK 202.5b-SEK 2,457,274,996.9837.3x-233.4x2.8x
Thu, 07 Nov 2024SEK 520.9bSEK 200.0b-SEK 2,882,322,661.7237.1x-180.7x2.6x
Sat, 05 Oct 2024SEK 607.5bSEK 200.2b-SEK 2,782,910,611.7639.8x-218.3x3x
Mon, 02 Sep 2024SEK 616.7bSEK 200.0b-SEK 2,803,885,491.0341.3x-219.9x3.1x
Wed, 31 Jul 2024SEK 588.0bSEK 199.8b-SEK 2,850,110,248.7341.1x-206.3x2.9x
Fri, 28 Jun 2024SEK 559.6bSEK 195.7b-SEK 3,063,087,249.0336.6x-182.7x2.9x
Sun, 26 May 2024SEK 553.7bSEK 196.1b-SEK 2,796,375,625.7836.5x-198x2.8x
Tue, 23 Apr 2024SEK 509.5bSEK 193.1b-SEK 3,154,359,283.3344.5x-161.5x2.6x
Thu, 21 Mar 2024SEK 514.8bSEK 192.5b-SEK 3,668,807,386.0344.1x-140.3x2.7x
Sat, 17 Feb 2024SEK 516.8bSEK 191.4b-SEK 4,057,378,134.3249.9x-127.4x2.7x
Mon, 15 Jan 2024SEK 558.9bSEK 191.5b-SEK 965,181,563.0048.1x-579.1x2.9x
Wed, 13 Dec 2023SEK 498.6bSEK 190.4b-SEK 1,068,107,791.0049.1x-466.8x2.6x
Fri, 10 Nov 2023SEK 473.9bSEK 190.1b-SEK 1,121,761,379.0050x-422.5x2.5x
Sun, 08 Oct 2023SEK 447.6bSEK 185.1b-SEK 2,032,952,939.0034.3x-220.2x2.4x
Tue, 05 Sep 2023SEK 466.5bSEK 185.5b-SEK 2,035,846,548.0038.4x-229.1x2.5x
Thu, 03 Aug 2023SEK 474.2bSEK 184.0b-SEK 988,067,967.0040x-480x2.6x
Sat, 01 Jul 2023SEK 480.3bSEK 179.2b-SEK 795,007,793.0044.7x-604.2x2.7x
Mon, 29 May 2023SEK 515.6bSEK 178.7b-SEK 548,140,751.0044.1x-940.7x2.9x
Wed, 26 Apr 2023SEK 510.1bSEK 173.2b-SEK 1,493,622,211.0035x-341.5x2.9x
Fri, 24 Mar 2023SEK 483.5bSEK 172.3b-SEK 1,416,096,910.0035.7x-341.4x2.8x
Sun, 19 Feb 2023SEK 504.2bSEK 169.7b-SEK 524,771,408.0037.2x-960.7x3x
Tue, 17 Jan 2023SEK 518.1bSEK 165.9bSEK 698.1m33.7x742.1x3.1x
Thu, 15 Dec 2022SEK 505.0bSEK 165.0bSEK 715.5m32.7x705.8x3.1x
Sat, 12 Nov 2022SEK 494.9bSEK 163.3bSEK 976.1m29.7x507x3x
Mon, 10 Oct 2022SEK 445.9bSEK 159.7b-SEK 228,344,656.0027.5x-1953x2.8x
Wed, 07 Sep 2022SEK 476.2bSEK 159.3b-SEK 73,328,792.0030.5x-6493.7x3x
Fri, 05 Aug 2022SEK 538.1bSEK 156.6b-SEK 304,003,999.0032.4x-1770x3.4x
Sun, 03 Jul 2022SEK 514.9bSEK 154.1bSEK 326.9m31.6x1575x3.3x
Tue, 31 May 2022SEK 567.7bSEK 155.0bSEK 404.1m38.8x1405.1x3.7x
Thu, 28 Apr 2022SEK 554.8bSEK 149.4bSEK 846.3m43.1x655.5x3.7x
Sat, 26 Mar 2022SEK 602.2bSEK 147.5bSEK 1.3b43.3x453.8x4.1x
Mon, 21 Feb 2022SEK 582.2bSEK 146.9bSEK 2.8b36.4x208x4x
Wed, 19 Jan 2022SEK 641.8bSEK 143.9bSEK 3.5b46x183.9x4.5x
Price to Earnings Ratio

183.9x


Total Market Cap: SEK 641.8bTotal Earnings: SEK 3.5bTotal Revenue: SEK 143.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Healthcare Sector Price to Earnings3Y Average -729.6x202320242025
Current Industry PE
  • Investors are relatively neutral on the Swedish Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 3.0x.
Past Earnings Growth
  • Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare sector?

SE Market-0.81%
Healthcare-1.22%
Medical Equipment1.31%
Life Sciences0.30%
Pharma0.085%
Healthtech-2.59%
Biotech-2.83%
Healthcare Services-2.95%
Industry PE
  • Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 189x.
    • Analysts are expecting annual earnings growth of 30.4%, which is lower than the prior year's growth of 104.8% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 76% over the next 5 years.
  • This is better than its past earnings decline of 36% per year.
  • In contrast, the Healthtech industry is expected to see its earnings grow by 30% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GETI B GetingeSEK 188.603.9%
+SEK 1.9b
-17.2%PE30.4x
IMP A SDB ImplanticaSEK 38.6512.8%
+SEK 1.2b
31.9%PS475.8x
CAMX CamurusSEK 601.002.0%
+SEK 676.3m
2.3%PE132.8x
EKTA B ElektaSEK 62.752.8%
+SEK 649.5m
-22.2%PE23.9x
BIOG B BioGaiaSEK 115.504.4%
+SEK 495.7m
9.7%PE34.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

XSPRAY

SEK 29.25

Xspray Pharma

7D

-32.0%

1Y

-20.7%

BIOG B

SEK 115.50

BioGaia

7D

4.4%

1Y

9.7%

BINV

SEK 31.00

BioInvent International

7D

-25.3%

1Y

79.0%

MCAP

SEK 620.00

MedCap

7D

2.0%

1Y

92.2%

VIMIAN

SEK 37.05

Vimian Group

7D

-6.1%

1Y

33.4%

IMP A SDB

SEK 38.65

Implantica

7D

12.8%

1Y

31.9%

ARJO B

SEK 36.86

Arjo

7D

1.5%

1Y

-13.7%

SECT B

SEK 264.25

Sectra

7D

-3.8%

1Y

47.4%

VITR

SEK 208.00

Vitrolife

7D

-4.3%

1Y

17.6%

RAY B

SEK 231.50

RaySearch Laboratories

7D

5.2%

1Y

156.9%